Sunday, January 28, 2007
EntreMed cancer drug deemed safe
Pharmaceutical Business Review - EntreMed has revealed that an an independent Data Safety Monitoring Board has conducted a favorable review of safety data from its breast cancer drug. The review was undertaken to assess the safety of the drug, MKC-1 in a phase II trial in patients
Source: www.pharmaceutical-business-review.com
Study probes bipolar disorder
Yale Daily News - Bipolar disorder, also known as manic depression, is one of the most common mental illnesses and a chronic medical Many who have bipolar disorder can control the symptoms with medication, but for some the disorder is disabling, said Dr. John
Source: www.yaledailynews.com
Biotechnology, Pharmaceutical and Life Science Reports Listing
BioPortfolio - Market for Over-the-Counter Pediatric Medication and Healthcare Products Needle-Free Drug Injection Systems and Safety to take share in second-line hormone-refractory prostate cancer market Bipolar DisorderNew treatments for bipolar depression set
Source: www.bioportfolio.com
Click here for more information about seasonal depression seasonal depression
